The pandemic of the new coronavirus has had a major global public health security impact. Even if research teams are working on vaccines, the average person may have to wait about 18 months to get it used. At the same time, some doctors are considering using existing vaccines to test whether they have some effect on alleviating the COVID-19 outbreak, such as the century-old cacao.
A microimage of the BCG strain (from: Wikipedia / Y tambe)
In self-healing patients with neo-coronavirus infection, the body already has specific antibodies, but it is not clear how long this immunity will last. We also know that SARS-CoV-2 mutates less quickly than the flu virus.
Of the dozens of COVID-19 vaccines currently under development, at least two have fast-forwarded to human trials, but the public may have to wait at least 18 months before they can be used.
But some scientists believe that the long-standing cacao can still be used to activate the body’s immune system to fight pathogens such as the new coronavirus.
In addition to cacao, some researchers are also considering using the BGC vaccine for anti-tb and early bladder cancer treatments as potential treatments for COVID-19.
The idea is that immune-enhanced mechanisms can defend against pathogens such as new coronaviruses, eliminating infection symptoms more quickly.
On Monday, the Australian government, in partnership with the World Health Organization, launched a six-month trial at the Murdoch Children’s Institute in Melbourne.
Bloomberg reported that the study involved about 4,000 health care workers who were divided into two groups receiving vaccines against influenza and tuberculosis.
Health care providers are being the first to be tested because they are about to experience another wave of COVID-19 cases in the coming months.
If the vaccine traditionally used to prevent TUBERculosis does work for COVID-19, it can be approved and applied more quickly than newly developed vaccines.
It should be noted that in addition to Australia, the Netherlands and Boston are also actively efasting similar potential cures for research.